NIACIN | A200484 | SUN PHARMACEUTICAL INDUSTRIES LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Abbott Laboratories et al v. Impax Laboratories Inc. 8 patentsANDA 202149, 090446, 090860, 090892, 200478, 200601, 200484, 201273, 201403, 201521niacin extended-release / simvastatin | D. Del. | 2010-11-24 | Terminated 2012-09-11 | — |
Abbott Laboratories et al v. Sun Pharmaceutical Industries, Ltd. et al 2 patentsANDA 200484niacin extended-release | E.D. Mich. | 2010-02-16 | Terminated 2010-04-19 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.2893
per ea
Lowest NADAC/Unit
$0.1492
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 47335061381NIACIN ER 1,000 MG TABLET | $0.2893 | EA | Generic | — | 2026-06-17 |
| 47335053981NIACIN ER 500 MG TABLET | $0.1492 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.